When Bonnet & Dick showed that in Acute Myeloid Leukaemia (AML), this subset of cells had an exclusive phenotype (CD34+/CD38–) [7], a new model to explain cancer cell heterogeneity was proposed: cancer stem cells (CSC) [8,9]. The gene discussed is CD34; the disease is acute myeloid leukemia.